α‐Synuclein seed amplification assay detects Lewy body co‐pathology in autosomal dominant Alzheimer's disease late in the disease course and dependent on Lewy pathology burden
Johannes Levin(The University of Melbourne), Matthew P. Frosch(Harvard University), Jee Hoon Roh(Korea University), Alan E. Renton(Icahn School of Medicine at Mount Sinai), Alexander Bernhardt(German Center for Neurodegenerative Diseases), Armin Giese(Ludwig-Maximilians-Universität München), Celeste M. Karch(Washington University in St. Louis), Mathias Jucker(TH Bingen University of Applied Sciences), Richard J. Perrin(Washington University in St. Louis), Simone Baiardi(Hospitais da Universidade de Coimbra), Peter R. Schofield(Neuroscience Research Australia), Randall J. Bateman(Washington University in St. Louis), Sarah Berman(University of Pittsburgh Medical Center), Francisco Lopera(Universidad de Antioquia), Erin Franklin(Washington University in St. Louis), C. Dirk Keene(University of Washington), Jonathan Vöglein(German Center for Neurodegenerative Diseases), Corinne Quadalti(Istituto delle Scienze Neurologiche di Bologna), Carlos Cruchaga(Washington University in St. Louis), Charlene Supnet(Washington University in St. Louis), Alisha Daniels(Inserm), Marcello Rossi(Institute of Neurological Sciences), Raquel Sánchez‐Valle(Universitat de Barcelona), Colin L. Masters(Mental Health Research Institute), Angela Mammana(Istituto delle Scienze Neurologiche di Bologna), Oskar Hansson(Lund University), Oliver Preische(Washington University in St. Louis), Catriona McLean(The Alfred Hospital), Patricio Chrem(Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia), Gregory S. Day(Washington University in St. Louis), John C. Morris(Mayo Clinic), Eric McDade(University of Pittsburgh), Günter U. Höglinger(German Center for Neurodegenerative Diseases), Nigel J. Cairns(Washington University in St. Louis), Laura Ibáñez(Washington University in St. Louis), Edward D. Huey(New York Psychoanalytic Society and Institute), Natalie S. Ryan(UK Dementia Research Institute), Jasmeer P. Chhatwal(Harvard University), Alison Goate(Icahn School of Medicine at Mount Sinai), Brian A. Gordon(Washington University in St. Louis), Jorge J. Llibre‐Guerra(Washington University in St. Louis), Jae‐Hong Lee(Asan Medical Center), Anna Hofmann(German Center for Neurodegenerative Diseases), James M. Noble(Harvard University), Chengjie Xiong(Ludwig-Maximilians-Universität München)
Cited by 37
Related Papers
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
|New England Journal of Medicine|2012|3.8k
National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease
|Alzheimer s & Dementia|2012|3.2k
National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach
|Acta Neuropathologica|2011|2.9k
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
|Movement Disorders|2017|2.3k
Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature
|Journal of Neuropathology & Experimental Neurology|2012|2.1k